FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:570-571 August 19, 1993 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Financial conflicts of interest in medicine -- what they are and how to deal with them -- constitute one of the most contentious issues in our profession. Organized medicine and its critics have debated whether clinicians should gain financially from their practice in any way other than through their direct fees or salaries for service., and the academic community and its critics have debated whether medical researchers should gain financially from companies whose products they are evaluating. Opinions vary greatly -- from those advocating that all conflicts of interest be proscribed to those arguing for disclosure and caveat emptor to . . . [Full Text of this Article]

References

Related Letters:

. . . And the Journal's Policies
Healing E., Rothman K. J., Kassirer J. P., Angell M.
Extract | Full Text  
N Engl J Med 1994; 330:503-504, Feb 17, 1994. Correspondence

This article has been cited by other articles:

• Fry-Revere, S., Malmstrom, D. B. (2009). More regulation of industry-supported biomedical research: are we asking the right questions?. J Law Med Ethics 37: 420-430  
• de Melo-Martin, I., Intemann, K. (2009). How do disclosure policies fail? Let us count the ways. FASEB J. 23: 1638-1642 [Abstract] [Full Text]  
• Montgomery, K., Oliver, A. L. (2009). Shifts in guidelines for ethical scientific conduct: how public and private organizations create and change norms of research integrity.. Social Studies of Science 39: 137-155 [Abstract]  
• Jacobs, J. J., Galante, J. O., Mirza, S. K., Zdeblick, T. (2006). Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?. JBJS 88: 1650-1663 [Full Text]  
• Yawn, B. P. (2006). Publication of Market-Driven Research in Medical Journals-Reply-I. Mayo Clin Proc. 81: 850-851 [Full Text]  
• Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., Nierenberg, A. A. (2005). Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry. Am. J. Psychiatry 162: 1957-1960 [Abstract] [Full Text]  
• Packer, S., Parke, D. W. II (2004). Ethical Concerns in Industry Support of Continuing Medical Education: The Con Side. Arch Ophthalmol 122: 773-776 [Full Text]  
• Tobin, M. J. (2003). Conflicts of Interest and AJRCCM: Restating Policy and a New Form to Upload. Am. J. Respir. Crit. Care Med. 167: 1161-1164 [Full Text]  
• Johns, M. M. E., Barnes, M., Florencio, P. S. (2003). Restoring Balance to Industry-Academia Relationships in an Era of Institutional Financial Conflicts of Interest: Promoting Research While Maintaining Trust. JAMA 289: 741-746 [Abstract] [Full Text]  
• Bekelman, J. E., Li, Y., Gross, C. P. (2003). Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review. JAMA 289: 454-465 [Abstract] [Full Text]  
• Barnes, M., Florencio, P. S. (2002). Financial Conflicts of Interest in Human Subjects Research: The Problem of Institutional Conflicts. J Law Med Ethics 30: 390-402  
• Drazen, J. M., Curfman, G. D. (2002). Financial Associations of Authors. NEJM 346: 1901-1902 [Full Text]  
• Lo, B., Wolf, L. E., Berkeley, A. (2000). Conflict-of-Interest Policies for Investigators in Clinical Trials. NEJM 343: 1616-1620 [Abstract] [Full Text]  
• McCrary, S. V., Anderson, C. B., Jakovljevic, J., Khan, T., McCullough, L. B., Wray, N. P., Brody, B. A. (2000). A National Survey of Policies on Disclosure of Conflicts of Interest in Biomedical Research. NEJM 343: 1621-1626 [Abstract] [Full Text]  
• Marck, P. B (2000). Recovering Ethics After 'Technics': developing critical text on technology. Nurs Ethics 7: 5-14 [Abstract]  
• Price, V. H., Angell, M., Wood, A. J.J. (1999). Authors' Conflicts of Interest: A Disclosure and Editors' Reply. NEJM 341: 1618-1619 [Full Text]  
• Fisher, E. S., Welch, H. G. (1999). Avoiding the Unintended Consequences of Growth in Medical Care: How Might More Be Worse?. JAMA 281: 446-453 [Abstract] [Full Text]  
• Kassirer, J. P., Angell, M. (1997). Controversial Journal Editorials. NEJM 337: 1460-1461 [Full Text]  
• Donnay, A., Baker, G. P., Fardon, D. F., Garfin, S. R., Saal, J. A., Simon, G., Deyo, R. A., Sternberg, E. M., Gordon, D. A., Brodkin, C. A., Mohr, S., Frumkin, H., Marsh, D. J., Scott, H. D., Fulks, J. R., Kern, D. G., Durand, K. T.H. (1997). Intimidation of Researchers by Special-Interest Groups. NEJM 337: 1314-1319 [Full Text]  
• Kassirer, J. P. (1995). My Years at the Journal -- So Far. NEJM 333: 654-655 [Full Text]  
• Emanuel, E. J., Steiner, D. (1995). Institutional Conflict of Interest. NEJM 332: 262-268 [Full Text]  
• Kassirer, J. P., Angell, M. (1994). The Journal's Policy on Cost-Effectiveness Analyses. NEJM 331: 669-670 [Full Text]  
• Brennan, T. A. (1994). Buying Editorials. NEJM 331: 673-675 [Full Text]  
• Healing, E., Rothman, K. J., Kassirer, J. P., Angell, M. (1994). . . . And the Journal's Policies. NEJM 330: 503-504 [Full Text]  
• Smith, R (1994). Conflict of interest and the BMJ. BMJ 308: 4-4 [Full Text]